FDA-approved GLP-1 peptides such as semaglutide and tirzepatide bind to the GLP-1 receptor, the same receptor a natural gut hormone uses to reduce hunger, slow digestion, and help regulate blood sugar
Independent medical reviews and regulatory analyses uniformly state: No controlled trials exist for arthritis, tendon injuries, or musculoskeletal pain
It is to create a trustworthy first point of support that listens carefully, explains clearly, recognises limits, and helps women move toward appropriate care
This is 40 times the standard subcutaneous dose, suggesting a wide safety margin
The peptide anti-inflammatory action is not limited to any single tissue type
Heres why dosage matters: It defines the therapeutic threshold: too little may not trigger any response